Table 1 Respondents’ characteristics
From: The association between cognitive impairment and breast and colorectal cancer screening utilization
Mammogram | Colonoscopy | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Overall N = 12,965 (100%) | Unimpaired N = 10,261 (79.1%) | Mildly impaired N = 2407 (18.6%) | Severely impaired N = 297 (2.3%) | p-valuef | Overall N = 24,782 (100%) | Unimpaired N = 19,914 (80.4%) | Mildly impaired N = 4338 (17.5%) | Severely impaired N = 530 (2.1%) | p-valuef | |
Age | ||||||||||
50–54 | 2278 (17.6%) | 1858 (18.1%) | 352 (14.6%) | 68 (22.9%) | < 0.001 | 4405 (17.8%) | 3674 (18.5%) | 628 (14.5%) | 103 (19.4%) | < 0.001 |
55–59 | 2593 (20.1%) | 2083 (20.3%) | 442 (18.4%) | 68 (22.9%) | 4950 (20.0%) | 4050 (20.3%) | 787 (18.1%) | 113 (21.3%) | ||
60–64 | 2833 (21.8%) | 2249 (21.9%) | 520 (21.6%) | 64 (21.6%) | 5325 (21.4%) | 4318 (21.7%) | 895 (20.6%) | 112 (21.1%) | ||
65–69 | 2845 (21.9%) | 2254 (22.0%) | 543 (22.6%) | 48 (16.2%) | 5176 (21.9%) | 4161 (20.9%) | 925 (21.3%) | 90 (17.0%) | ||
70–74 (75)a | 2416 (18.6%) | 1817 (17.7%) | 550 (22.9%) | 49 (16.5%) | 4926 (19.9%) | 3711 (18.6%) | 1103 (25.4%) | 112 (21.1%) | ||
Sex | ||||||||||
Female | 12,965 (100%) | 10,261 (100%) | 2407 (100%) | 297 (100%) | – | 13,345 (53.9%) | 10,543 (52.9%) | 2499 (57.6%) | 303 (57.2%) | < 0.001 |
Male | – | – | – | – | 11,437 (46.1%) | 9371 (47.1%) | 1839 (42.4%) | 277 (42.8%) | ||
Race-ethnicityb | ||||||||||
NHW | 9413 (72.6%) | 7453 (72.6%) | 1744 (72.5%) | 216 (72.7%) | = 0.457 | 18,241 (73.6%) | 14,667 (73.6%) | 3205 (73.9%) | 369 (69.6%) | = 0.005 |
NHB | 1483 (11.4%) | 1159 (11.3%) | 295 (12.3%) | 29 (9.8%) | 2690 (10.9%) | 2104 (10.6%) | 519 (12.0%) | 67 (12.6%) | ||
NHO | 808 (6.3%) | 656 (6.4%) | 135 (5.6%) | 17 (5.7%) | 1562 (6.3%) | 1281 (6.4%) | 248 (5.8%) | 33 (6.2%) | ||
Hispanic | 1261 (9.7%) | 993 (9.7%) | 233 (9.7%) | 35 (11.8%) | 2289 (9.2%) | 1862 (9.4%) | 366 (8.4%) | 61 (11.5%) | ||
Educationc | ||||||||||
≤ HS | 4482 (34.7%) | 3362 (32.9%) | 980 (40.9%) | 140 (47.5%) | < 0.001 | 8863 (35.9%) | 6748 (34.0%) | 1842 (42.7%) | 273 (52.0%) | < 0.001 |
> HS | 8436 (65.3%) | 6866 (67.1%) | 1415 (59.1%) | 155 (52.5%) | 15,804 (64.1%) | 13,083 (66.0%) | 2469 (57.3%) | 252 (48.0%) | ||
Marital status | ||||||||||
Single | 1203 (9.4%) | 928 (9.2%) | 238 (10.0%) | 37 (12.6%) | < 0.001 | 2593 (10.6%) | 2002 (10.2%) | 505 (11.8%) | 86 (16.5%) | < 0.001 |
Live with spouse | 6628 (51.9%) | 5479 (54.2%) | 1049 (44.1%) | 100 (34.0%) | 13,617 (55.8%) | 11,384 (58.0%) | 2031 (47.6%) | 202 (38.8%) | ||
Otherd | 4945 (38.7%) | 3699 (36.6%) | 1089 (45.8%) | 157 (53.4%) | 8195 (33.6%) | 6229 (31.8%) | 1733 (40.6%) | 233 (44.7%) | ||
Insurance coverage | ||||||||||
Insured | 12,221 (94.5%) | 9668 (94.4%) | 2278 (94.9%) | 275 (92.6%) | = 0.249 | 23,251 (94.0%) | 18,643 (93.8%) | 4109 (94.9%) | 499 (94.3%) | = 0.033 |
Uninsured | 714 (5.5%) | 569 (5.6%) | 123 (5.1%) | 22 (7.4%) | 1475 (6.0%) | 1223 (6.2%) | 222 (5.1%) | 30 (5.7%) | ||
Cancer diagnosed | ||||||||||
Yes | 2205 (17.0%) | 1591 (15.5%) | 553 (23.0%) | 61 (20.5%) | < 0.001 | 3981 (16.1%) | 2952 (14.8%) | 926 (21.4%) | 103 (19.4%) | < 0.001 |
No | 10,747 (83.0%) | 8658 (84.5%) | 1853 (77.0%) | 236 (79.5%) | 20,772 (83.9%) | 16,935 (85.2%) | 3410 (78.6%) | 427 (80.6%) | ||
Chronic disease scoree | 1.85 ± 1.60 | 1.62 ± 1.48 | 2.62 ± 1.75 | 3.12 ± 1.96 | < 0.001 | 1.90 ± 1.63 | 1.70 ± 1.51 | 2.67 ± 1.81 | 3.22 ± 1.02 | < 0.001 |